Pages that link to "Q33943954"
Jump to navigation
Jump to search
The following pages link to An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease (Q33943954):
Displaying 50 items.
- The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. (Q24533492) (← links)
- Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements (Q24632752) (← links)
- Mitochondrial biology and Parkinson's disease (Q26824090) (← links)
- Apaf-1 inhibitors protect from unwanted cell death in in vivo models of kidney ischemia and chemotherapy induced ototoxicity (Q28543956) (← links)
- Effect of zinc and paraquat co-exposure on neurodegeneration: Modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats (Q28572108) (← links)
- Human gene therapy and imaging in neurological diseases (Q31023442) (← links)
- Identification of mouse AAV capsid-specific CD8+ T cell epitopes (Q33226431) (← links)
- Small molecule inhibitors of Apaf-1-related caspase- 3/-9 activation that control mitochondrial-dependent apoptosis (Q33229065) (← links)
- Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression (Q33713384) (← links)
- Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage (Q34245037) (← links)
- Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats (Q34436780) (← links)
- Advances in gene therapy for movement disorders. (Q34656049) (← links)
- Application of adeno-associated viral vectors in behavioral research (Q34987177) (← links)
- Adeno-associated virus-mediated antiapoptotic gene delivery: in vivo gene therapy for neurological disorders (Q34987202) (← links)
- Gene therapy for treatment of cerebral ischemia using defective recombinant adeno-associated virus vectors (Q34987206) (← links)
- Neuroprotective gene therapy against acute neurological insults (Q35038275) (← links)
- Targeting programmed cell death in neurodegenerative diseases (Q35120138) (← links)
- Physiological and pathological roles of Apaf1 and the apoptosome. (Q35136123) (← links)
- Gene therapy progress and prospects: Parkinson's disease (Q35206326) (← links)
- Adeno-associated viral vectors for Parkinson's disease (Q35216667) (← links)
- Adeno-associated viral vectors for retinal gene transfer. (Q35566831) (← links)
- Neuronal pathology in Parkinson's disease (Q35886715) (← links)
- Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors (Q36150495) (← links)
- Adeno-associated virus vectors: potential applications for cancer gene therapy (Q36165834) (← links)
- Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems (Q36311189) (← links)
- Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. (Q36368045) (← links)
- Immunology of neurological gene therapy: how T cells modulate viral vector-mediated therapeutic transgene expression through immunological synapses (Q36498768) (← links)
- Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults (Q36690552) (← links)
- Molecular pathways of programmed cell death in experimental Parkinson's disease. (Q36961419) (← links)
- Cell death in brain development and degeneration: control of caspase expression may be key! (Q37152010) (← links)
- Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex (Q37198947) (← links)
- Parkin gene therapy (Q37364841) (← links)
- Innate and adaptive immunity for the pathobiology of Parkinson's disease (Q37401280) (← links)
- Molecules that modulate Apaf-1 activity (Q37680800) (← links)
- Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond (Q37880904) (← links)
- MPTP mouse models of Parkinson's disease: an update (Q38070400) (← links)
- Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems. (Q38492748) (← links)
- Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease (Q38693732) (← links)
- Apaf1 inhibition promotes cell recovery from apoptosis. (Q38836005) (← links)
- The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration (Q38860761) (← links)
- Gene therapy targeting mitochondrial pathway in Parkinson's disease (Q38957332) (← links)
- BAG1 is neuroprotective in in vivo and in vitro models of Parkinson's disease (Q38967787) (← links)
- p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism (Q39401687) (← links)
- Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1. (Q39527536) (← links)
- Apocytochrome c blocks caspase-9 activation and Bax-induced apoptosis (Q40694903) (← links)
- Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. (Q40726384) (← links)
- Expression of BCL-2 via adeno-associated virus vectors rescues thalamic neurons after visual cortex lesion in the adult rat. (Q43982222) (← links)
- Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. (Q44451960) (← links)
- Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies. (Q44529077) (← links)
- Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. (Q44777514) (← links)